US equities
|
MU
$1,080.51
▲+3.34%
NVDA
$237.01
▼-0.93%
SNDK
$1,724.93
▲+3.88%
AMD
$642.66
▼-1.04%
SPCX
$168.88
▼-1.77%
INTC
$113.37
▲+0.77%
TSLA
$375.62
▼-1.33%
AAPL
$334.79
▲+0.35%
MU
$1,080.51
▲+3.34%
NVDA
$237.01
▼-0.93%
SNDK
$1,724.93
▲+3.88%
AMD
$642.66
▼-1.04%
SPCX
$168.88
▼-1.77%
INTC
$113.37
▲+0.77%
TSLA
$375.62
▼-1.33%
AAPL
$334.79
▲+0.35%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about TRP/8803
Recent news which mentions TRP/8803
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
Tickers
NEWS
TYPTF
Tags
Phase 2 Clinical Trial
Health Care
Psychedelics Research
From
Benzinga